CIK 0001124524
- Accelerated filer
Cryoport, Inc.
Sign in to watch- Ticker
- CYRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 880313393
- Phone
- +1 949-232-1900
- Business address
- 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027
- Former names
- CRYOPORT SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,702,237
- in 2 filings, $1.5M under 10b5-1 plans
Net −$1,702,237. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-10 | SHELTON JERRELL President, CEO | Sale | −10,619 | $77.97 | $828K | 618,723 |
| 2021-11-10 | SHELTON JERRELL President, CEO | Sale | −22,554 | $78.73 | $1.8M | 596,169 |
| 2021-11-10 | SHELTON JERRELL President, CEO | Sale | −25,167 | $79.81 | $2.0M | 571,002 |
| 2021-11-10 | SHELTON JERRELL President, CEO | Sale | −6,910 | $80.66 | $557K | 564,092 |
| 2021-11-10 | SHELTON JERRELL President, CEO | Option exercise · Option to purchase common stock | −8,334 | 0 | ||
| 2021-11-10 | SHELTON JERRELL President, CEO | Option exercise · Option to purchase common stock | −56,916 | 26,418 | ||
| 2021-10-21 | HANCOCK DANIEL M Director | Option exercise | +11,217 | $14.35 | $161K | 15,844 |
| 2021-10-21 | HANCOCK DANIEL M Director | Sale | −5,900 | $75.29 | $444K | 9,944 |
| 2021-10-21 | HANCOCK DANIEL M Director | Sale | −5,317 | $76.24 | $405K | 4,627 |
| 2021-10-21 | HANCOCK DANIEL M Director | Option exercise · Option to purchase common stock | −11,217 | 0 | ||
| 2021-10-20 | HANCOCK DANIEL M Director | Option exercise | +3,783 | $14.35 | $54K | 8,410 |
| 2021-10-20 | HANCOCK DANIEL M Director | Sale | −3,783 | $75.17 | $284K | 4,627 |
| 2021-10-20 | HANCOCK DANIEL M Director | Option exercise · Option to purchase common stock | −3,783 | 11,217 | ||
| 2021-10-14 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise | +49,918 | $7.80 | $389K | 81,335 |
| 2021-10-14 | STEFANOVICH ROBERT Chief Financial Officer | Sale | −43,738 | $67.60 | $3.0M | 37,597 |
| 2021-10-14 | STEFANOVICH ROBERT Chief Financial Officer | Sale | −6,180 | $68.38 | $423K | 31,417 |
| 2021-10-14 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise · Options to purchase common stock | −49,918 | 7,566 | ||
| 2021-09-27 | HANCOCK DANIEL M Director | Option exercise | +10,000 | $14.35 | $144K | 14,627 |
| 2021-09-27 | HANCOCK DANIEL M Director | Sale | −10,000 | $70.17 | $702K | 4,627 |
| 2021-09-27 | HANCOCK DANIEL M Director | Option exercise · Option to purchase common stock | −10,000 | 15,000 |
Page 17 of 28 · 541 trades